International Digital Pathology Consultation Services of Kindstar Global - Cleveland Was Signed Successfully
On November 17, 2019, Kindstar Global and Cleveland Medical Center signed an agreement of the "Cleveland - Kindstar Global International Digital Pathology Consultation Services” in the 25th Academic Conference of the Chinese Medical Association Pathology and the 9th Annual Meeting of Chinese Pathology, Zhengzhou International Convention and Exhibition Center.
Dr. Shiang Huang, CEO of Kindstar Global stated that Kindstar has always adhered to our promise of "Patients’ interest is our priority, doctors’ need come first", and has worked outstandingly in specialized diagnostic tests. In the past 15 years, Kindstar has provided high-end, authoritative and high-quality testing services to medical institutions at all levels. We look forward to a joining force with the Cleveland Medical Center to introduce top medical resources from the United States integrated with Kindstar Globar's extensive network in specialized tests, and build an international digital pathology consultation platform together. It can benefit many patients especially for the unique and challenging cases with the intractable, rare or complicated diseases.
Prof. Brian Rubin, the director of Pathology Department and the director of Soft Tissue Pathology Department, Cleveland Medical Center, is a founding member of the International Society of Bone and Soft Tissue Pathology. He said that the Department of Pathology of Cleveland Medical Center has a global leading position in clinical diagnosis and professional training. It has a large number of professional knowledge systems, experienced pathologists in diagnosis, and has more than 20 year history for the construction of sub-specialty team. Since its establishment, they have always adhered to the concept of "patient first" and hope to bring this mission to China. The cooperation of digital pathology consultant service with Kindstar is just a beginning. We hope that we can cooperate more closely with medical institutions in China through Kindstar in clinical diagnosis, education and training in the future.
Prof. Wang Guoping, director of Pathology Institute, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, warmly congratulated on the cooperation between Cleveland Medical Center and Kindstar Global. He also ardent hopes that all third-party diagnostic institutions could make a greater contribution in providing more high-quality services for patients, promoting the development of pathology and healthcare in China.
The Cleveland Department of Pathology has been ranked one of top two clinical diagnostics institutes in the United States for many years. It has nationally- and internationally-renowned pathologists in diagnosis, research, and treatment of human diseases. It also has a global leading position in professional pathology training and clinical laboratory diagnostics. Currently, the Cleveland Department of Pathology has more than 1,800 staff, including approximately 105 pathologists and 60 residents. They have many years of clinical experience and in-depth understanding of various diseases; they can make accurate morphological classification and diagnosis, especially for unique and challenging cases, the diagnosis and grading of certain types of tumors. The Department of Pathology at Cleveland Hospital is committed to providing world-class excellence pathological diagnostics and cutting-edge pathology research, and the best patient services to improve human health.
Dr. Huang Shiang (center), CEO of Kindstar Global, Prof. Brian Rubin, director of Cleveland Medical Center (right), director of Cleveland Pathology and Medical Laboratory, and Dr. Yu Jiangsheng (left), general manager of Binsheng Technology Co., Ltd. signed the agreement. Mr. Tu Zanbing (back left), chief operating officer of Kindstar Global, and Prof. Yang Bin (back right), director of the International Cooperation Department of Cleveland Pathology, witnessed the signing ceremony.
Representatives from both party, and Prof. Wang Guoping, director of the Institute of Pathology, Tongji Hospital, Tongji Medical School of Huazhong University of Science and technology, unveiled the event, which officially starts a new era of international digital pathology consultation in China.